Arrow Clinical Trials

01/23/2026

Come see what available at the Senior Expo 548 N Nova Road and say hello to Arrow Clinical Trials.

01/22/2026

View the Port Orange for Thursday, January 22, 2026

01/22/2026

Come and visit us at the Hometown News Volusia Lifestyle and Wellness Expo on Wednesday, January 28th at the Sunshine Park Plaza in South Daytona and visit our Community Ambassador Shawn Geopfert, who is also interviewed in this article on behalf of Arrow Clinical Trials

View the Port Orange for Thursday, January 22, 2026

01/15/2026

Our team was fortunate to be part of this important study. We appreciate the collaboration and the opportunity to contribute to research that advances patient care.

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

01/13/2026

High Lp(a) in Women: What It Means for Long-Term Heart Health — A New Study Opportunity Coming at Arrow Soon

Very high lipoprotein(a) levels predict 30‑year cardiovascular risk in healthy women

https://www.epocrates.com/online/contextuallink/article/very-high-lipoprotein-a-levels-predict-30-year-cardiovascular-risk-in?utm_source=share&utm_medium=member_web

01/05/2026

Advancing Heart Health Close to Home: We’re Preparing for a New Lipoprotein(a) Heart Health Study

High levels of lipoprotein(a) often go undetected and can afflict seemingly healthy people. A clinical trial will show whether lowering levels can reduce risk of heart disease.

12/12/2025

12/04/2025

Emerging insights from leading metabolic experts, including our own CMO Dr. Charles Ross, highlight a growing concern around GLP-1 medications: while they effectively support weight reduction, they may also accelerate muscle loss when not paired with the right strategy. As more patients turn to GLP-1 therapies, understanding how these drugs influence muscle health—and what can be done to protect strength and long-term function—has become essential.

Learn how Ozempic, Mounjaro, diet, and exercise affect muscle loss, and discover how protein and resistance training help preserve strength during weight loss.

12/03/2025

Our CEO Dr. David Billmeier is representing Arrow Clinical Trials at the prestigious CTAD Alzheimer’s Disease Convention in San Diego, diving into the newest breakthroughs, emerging treatments, and cutting-edge research shaping the future of Alzheimer’s care. A strong moment for Arrow’s commitment to advancing science and improving patient lives.

11/25/2025

Dr. Billmeier sharing the Arrow Clinical Trials story with the friends at Ormond Beach Council on Aging.

11/23/2025

All set up at The Brannon Center for today’s senior expo.